【レポートの概要（一部）】
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models
Chapter 2: Executive Summary
2.1. Key Findings of The Study
2.2. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.3. Porter’S Five Forces Analysis
3.3.1. Moderate Bargaining Power of Buyers
3.3.2. Low Bargaining Power of Suppliers
3.3.3. Moderate Threat of Substitutes
3.3.4. Low Threat of New Entrants
3.3.5. Moderate Competitive Rivalry
3.4. Top Player Positioning
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. Surge In Severe Road Accidents
3.5.1.2. Significant Increase In Surgical Procedures
3.5.2. Restraint
3.5.2.1. High Cost of These Drugs
3.5.3. Opportunity
3.5.3.1. Various Growth Opportunities In Emerging Economies
Chapter 4: Antifibrinolytic Drugs Market, By Indication
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Gynecology
4.2.1. Key Market Trends And Opportunities
4.2.2. Market Size And Forecast
4.2.3. Market Share Analysis, By Country
4.3. Hereditary Angioedema
4.3.1. Key Market Trends And Growth Opportunities
4.3.2. Market Size And Forecast
4.3.3. Market Share Analysis, By Country
4.4. Fibrinolytic Response Testing
4.4.1. Key Market Trends And Opportunities
4.4.2. Market Size And Forecast
4.4.3. Market Share Analysis, By Country
4.5. Surgeries
4.5.1. Key Market Trends And Opportunities
4.5.2. Market Size And Forecast
4.5.3. Market Share Analysis, By Country
4.6. Others
4.6.1. Key Market Trends And Opportunities
4.6.2. Market Size And Forecast
4.6.3. Market Share Analysis, By Country
Chapter 5: Antifibrinolytic Drugs Market, By End User
5.1. Overview
5.1.1. Market Size And Forecast
5.2. Hospitals
5.2.1. Market Size And Forecast
5.2.2. Market Share Analysis, By Country
5.3. Ambulatory Surgery Centers
5.3.1. Market Size And Forecast
5.3.2. Market Share Analysis, By Country
5.4. Trauma Centers
5.4.1. Market Size And Forecast
5.4.2. Market Share Analysis, By Country
Chapter 6: Antifibrinolytic Drugs Market, By Region
6.1. Overview
6.1.1. Market Size And Forecast
6.2. North America
6.2.1. Key Market Trends And Opportunities
6.2.2. Market Size And Forecast, By Country
6.2.3. Market Size And Forecast, By Indication
6.2.4. Market Size And Forecast, By End User
6.2.5. U.S.
6.2.5.1. U.S. Market Size And Forecast, By Indication
6.2.5.2. U.S. Market Size And Forecast, By End User
6.2.6. Canada
6.2.6.1. Canada Market Size And Forecast, By Indication
6.2.6.2. Canada Market Size And Forecast, By End User
6.2.7. Mexico
6.2.7.1. Mexico Market Size And Forecast, By Indication
6.2.7.2. Mexico Market Size And Forecast, By End User
6.3. Europe
6.3.1. Key Growth Factors And Opportunities
6.3.2. Market Size And Forecast, By Country
6.3.3. Market Size And Forecast, By Indication
6.3.4. Market Size And Forecast, By End User
6.3.5. Germany
6.3.5.1. Germany Market Size And Forecast, By Indication
6.3.5.2. Germany Market Size And Forecast, By End User
6.3.6. France
6.3.6.1. France Market Size And Forecast, By Indication
6.3.6.2. France Market Size And Forecast, By End User
6.3.7. Uk
6.3.7.1. Uk Market Size And Forecast, By Indication
6.3.7.2. Uk Market Size And Forecast, By End User
6.3.8. Italy
6.3.8.1. Italy Market Size And Forecast, By Indication
6.3.8.2. Italy Market Size And Forecast, By End User
6.3.9. Rest of Europe
6.3.9.1. Rest of Europe Market Size And Forecast, By Indication
6.3.9.2. Rest of Europe Market Size And Forecast, By End User
6.4. Asia-Pacific
6.4.1. Key Growth Factors And Opportunities.
6.4.2. Market Size And Forecast, By Country
6.4.3. Market Size And Forecast, By Indication
6.4.4. Market Size And Forecast, By End User
6.4.5. Japan
6.4.5.1. Japan Market Size And Forecast, By Indication
6.4.5.2. Japan Market Size And Forecast, By End User
6.4.6. China
6.4.6.1. China Market Size And Forecast, By Indication
6.4.6.2. China Market Size And Forecast, By End User
6.4.7. India
6.4.7.1. India Market Size And Forecast, By Indication
6.4.7.2. India Market Size And Forecast, By End User
6.4.8. Rest of Asia-Pacific
6.4.8.1. Rest of Asia-Pacific Market Size And Forecast, By Indication
6.4.8.2. Rest of Asia – Pacific Market Size And Forecast, By End User
6.5. Lamea
6.5.1. Key Growth Factors And Opportunities
6.5.2. Market Size And Forecast, By Country
6.5.3. Market Size And Forecast, By Indication
6.5.4. Market Size And Forecast, By End User
6.5.5. Brazil
6.5.5.1. Brazil Market Size And Forecast, By Indication
6.5.5.2. Brazil Market Size And Forecast, By End User
6.5.6. Saudi Arabia
6.5.6.1. Saudi Arabia Market Size And Forecast, By Indication
6.5.6.2. Saudi Arabia Market Size And Forecast, By End User
6.5.7. South Africa
6.5.7.1. South Africa Market Size And Forecast, By Indication
6.5.7.2. South Africa Market Size And Forecast, By End User
6.5.8. Rest of Lamea
6.5.8.1. Rest of Lamea Market Size And Forecast, By Indication
6.5.8.2. Rest of Lamea Market Size And Forecast, By End User
Chapter 7: Company Profiles
7.1. Akorn Inc.
7.1.1. Company Overview
7.1.2. Company Snapshot
7.1.3. Operating Business Segments
7.1.4. Product Portfolio
7.1.5. Business Performance
7.2. Aurobindo Pharma Limited
7.2.1. Company Overview
7.2.2. Company Snapshot
7.2.3. Operating Business Segments
7.2.4. Product Portfolio
7.2.5. Business Performance
7.3. Bayer Ag
7.3.1. Company Overview
7.3.2. Company Snapshot
7.3.3. Operating Business Segments
7.3.4. Product Portfolio
7.3.5. Business Performance
7.4. Ferring Holding Sa
7.4.1. Company Overview
7.4.2. Company Snapshot
7.4.3. Operating Business Segments
7.4.4. Product Portfolio
7.4.5. Business Performance
7.5. Mylan N.V.
7.5.1. Company Overview
7.5.2. Company Snapshot
7.5.3. Operating Business Segments
7.5.4. Product Portfolio
7.5.5. Business Performance
7.6. Novartis International Ag (Sandoz)
7.6.1. Company Overview
7.6.2. Company Snapshot
7.6.3. Operating Business Segments
7.6.4. Product Portfolio
7.6.5. Business Performance
7.7. Pfizer Inc.
7.7.1. Company Overview
7.7.2. Company Snapshot
7.7.3. Operating Business Segments
7.7.4. Product Portfolio
7.7.5. Business Performance
7.8. Sanofi S.A.
7.8.1. Company Overview
7.8.2. Company Snapshot
7.8.3. Operating Business Segments
7.8.4. Product Portfolio
7.8.5. Business Performance
7.9. Takeda Pharmaceutical Company Limited
7.9.1. Company Overview
7.9.2. Company Snapshot
7.9.3. Operating Business Segments
7.9.4. Product Portfolio
7.9.5. Business Performance
7.10. Vitruvias Therapeutics Inc.
7.10.1. Company Overview
7.10.2. Company Snapshot
7.10.3. Operating Business Segments
7.10.4. Product Portfolio
7.10.5. Business Performance
7.10.1. Key Strategic Moves And Developments
【レポート販売概要】
■ タイトル：抗線溶薬の世界市場：疾患別（婦人科、遺伝性血管浮腫、線溶反応試験、手術、その他）、エンドユーザー別（病院＆クリニック、外来手術センター、医療専門プロセス）■ 英文：Antifibrinolytic Drugs Market by Indication (Gynecology, Hereditary Angiedema, Fibrinolytic Response Testing, Surgeries, and Others) and End user (Hospitals & Clinics, Ambulatory Surgical Centers, and Healthcare Specialty Process): Global Opportunity Analysis and Industry Forecast, 2019–2026
■ 発行日：2019年12月21日
■ 調査会社：Allied Market Research
■ 商品コード：AMR20FE017
■ 調査対象地域：グローバル
- メキシコの患者診察機器市場見通し（～2021）Mexico Patient Examination Devices Market Outlook to 2021 Summary GlobalData’s new report, "Mexico Patient Examination Devices Market Outlook to 2021", provides key market data on the Mexico Patient Examination Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Stethoscopes and Thermometers. The r …
- 患者エンゲージメント技術の世界市場：料金体系、置き換え動向、選定基準、購買行動Patient engagement technology is increasingly being adopted by healthcare providers, payers, and patients across the globe, particularly in the U.S. This report provides qualitative assessment of the patient engagement technologies in terms of pricing, vendor replacement trends, and selection criteria of adopting patient engagement technologies from provider perspective. The market is expected to …
- 手術前計画ソフトウェアの世界市場：種類別（オフプレミス、オンプレミス）、用途別（整形外科[一般的な整形外科手術、変形矯正、骨折管理、および関節再建]、脳神経外科、歯科および歯列矯正用、およびその他）、エンドユーザー別（病院、整形外科、リハビリテーションセンター）Surgical preoperative planning software is a specialized form of software that manages different surgeries such as neurology and orthopedic surgeries. Different modalities such as neurology, dental & orthopedic surgeries, including joint, reconstruction, and deformity correction can be planned accordingly with the aid of this software. In addition, it creates digitally accurate data that can be ea …
- 希土類金属（レアメタル）の世界市場2015-2019Rare earth metals have unique physical and chemical properties, which make them suitable to alloy with other metals for use in applications that require enhanced magnetic strength, high temperature resistance, and other properties. They are widely used in the manufacture of magnets for wind turbine generators and for the electrodes in metal hydride batteries. These metals are also used in various …
- 全地球航法衛星システム（GNSS）の世界市場2016-2020GNSS provides signals from space, which help determine the location of the user by using the timing and position of the data transmitted from the space. GNSS radio signals are complex, as they have a frequency of about 1.5 GHz (gigahertz) per 1.5 billion cycles per second. GNSS requires frequencies that are higher than FM radio, but lower than a microwave oven, for proper functioning. The GNSS sig …
- 血液透析/腹膜透析の世界市場The global dialysis market has been segmented into two broad segments, namely, hemodialysis (HD) and peritoneal dialysis (PD). The hemodialysis segment is further categorized into hemodialysis products and services. The market for water treatment systems is also considered under the scope of study. The water treatment systems market is segmented into central water disinfection system and portable …
- 肝胆道疾患(Hepatobiliary Disease)：世界の治験レビュー（2015年上半期版）Hepatobiliary Disease Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Hepatobiliary Disease Global Clinical Trials Review, H1, 2015" provides data on the Hepatobiliary Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatobiliary Disease. It includes an overview of the trial numbers and the …
- グローバル装甲車・対IED防御車両市場（2014-2024）：地域別分析Synopsis This report offers detailed analysis of the global Armored and Counter IED Vehicles market over the next ten years, and provides extensive market size forecasts by country and sub sector. It covers the key technological and market trends in the Armored and Counter IED Vehicles market. Summary "The Global Armored and Counter IED Vehicles Market 2014-2024 - Country Analysis: Market Profile" …
- 世界主要国の潜血検査（医療機器）市場The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technolog …
- 世界の高級ホテル市場Summary The global luxury hotels market's performance has recovered from the slowdown recorded at the beginning of the historic period (2009-2013) due to the financial crisis and recession. Overall, growth was recorded in the four markets - Americas, Asia-Pacific, Europe, Middle East and Africa - across all key performance indicators (KPIs) during the historic period. Growth is expected to continu …
- 世界のバイオフォトニクス（Biophotonics）市場動向（2012-2016）TechNavio's analysts forecast the Global Biophotonics market to grow at a CAGR of 10.03 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Biophotonics market has also been witnessing the expansion of application. However, the high cost could pose a challenge to the growth of this market. TechNavio's report, t …
- 世界のテクニカルテキスタイル（Technical Textile）市場動向（2012-2016）TechNavio's analysts forecast the Global Technical Textile market to grow at a CAGR of 4.02 percent over the period 2012-2016. One of the key factors contributing to this market growth is the innovation in technology. The Global Digital Cinema Screen market has also been witnessing the introduction of electronic in textiles. However, the high cost of raw materials and power could pose a challenge …
- Ulcerative Colitis：グローバル臨床試験レビューH2, 2013Ulcerative Colitis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Ulcerative Colitis Global Clinical Trials Review, H2, 2013" provides data on the Ulcerative Colitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ulcerative Colitis. It includes an overview of the trial numbers and their recruitme …
- ポリイソブチレン（PIB）の世界市場2017-2021ABSTRACTAbout Polyisobutylene Polyisobutylene (PIB) is an elastic, rubbery, semi-solid, or viscous substance. It is odorless and tasteless and is mainly used in automotive applications due to its impermeability to gases. Polyisobutylene (PIB), also called butyl rubber, is an elastomer whose structure is similar to polyethylene and polypropylene. PIB is available as viscous liquid that has a molecu …
- ギヤモータの世界市場動向・予測（～2021）The global gear motors market is projected to grow at a CAGR of 5.8% from 2016 to 2021, to reach USD 23.94 Billion by 2021. This growth can be attributed to increasing wind power installations and growing concerns regarding the efficiency and cost-effectiveness of mechanical power transmission technologies. The report segments the gear motors market on the basis of major end-user industries into w …
